Industry Satellite Symposia Sessions

Oncogene Addicated

← Back to the Areas of Interest  

INVITATION

AstraZeneca - Improving patient outcomes in early-stage and advanced EGFR-mutant NSCLC: Emerging strategies

View the full invitation

INVITATION

Amgen - Targeting the undruggable in KRAS-mutated advanced NSCLC and mCRC

View the full invitation

INVITATION

Boehringer Ingelheim - Treatment considerations for advanced NSCLC: Now and in the future

View the full invitation